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Abstract
Background: The lack of effective use of research evidence in policy-making is a major challenge in most low- and 
middle-income countries (LMICs). There is need to package research data into effective policy tools that will help 
policy-makers to make evidence-informed policy regarding infectious diseases of poverty (IDP). The objective of 
this study was to assess the usefulness of training workshops and mentoring to enhance the capacity of Nigerian 
health policy-makers to develop evidence-informed policy brief on the control of IDP. 
Methods: A modified “before and after” intervention study design was used in which outcomes were measured on 
the target participants both before the intervention is implemented and after. A 4-point Likert scale according to the 
degree of adequacy; 1 = “grossly inadequate,” 4 = “very adequate” was employed. The main parameter measured was 
participants’ perceptions of their own knowledge/understanding. This study was conducted at subnational level and 
the participants were the career health policy-makers drawn from Ebonyi State in the South-Eastern Nigeria. A one-
day evidence-to-policy workshop was organized to enhance the participants’ capacity to develop evidence-informed 
policy brief on IDP in Ebonyi State. Topics covered included collaborative initiative; preparation and use of policy 
briefs; policy dialogue; ethics in health policy-making; and health policy and politics. 
Results: The preworkshop mean of knowledge and capacity ranged from 2.49-3.03, while the postworkshop mean 
ranged from 3.42–3.78 on 4-point scale. The percentage increase in mean of knowledge and capacity at the end 
of the workshop ranged from 20.10%–45%. Participants were divided into 3 IDP mentorship groups (malaria, 
schistosomiasis, lymphatic filariasis [LF]) and were mentored to identify potential policy options/recommendations 
for control of the diseases for the policy briefs. These policy options were subjected to research evidence synthesis 
by each group to identify the options that have the support of research evidence (mostly systematic reviews) from 
PubMed, Cochrane database and Google Scholar. After the evidence synthesis, five policy options were selected out 
of 13 for malaria, 3 out of 10 for schistosomiasis and 5 out of 11 for LF. 
Conclusion: The outcome suggests that an evidence-to-policy capacity enhancement workshop combined with a 
mentorship programme can improve policy-makers’ capacity for evidence-informed policy-making (EIP).
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Implications for policy makers
• Policy-makers need to have access to the right information on infectious diseases of poverty (IDP) at the right time to inform decisions that 
draw on the evidence of what works. There are numerous reports which have shown that the availability of timely, suitably packaged and 
policy relevant research evidence is important in supporting increased use of research evidence in the policy processes.
• Policy-makers’ knowledge and capacity to develop evidence-informed policy materials such as policy briefs can be enhanced via evidence-to-
policy training workshops and mentorship programme.
• Any capacity enhancement initiative designed to enable policy-makers to prepare and use policy briefs effectively and efficiently, should 
contain knowledge and skills building components that will improve the following: (i) Policy-makers’ ability to clarify policy relevant 
problems; (ii) Policy-makers’ ability to decide on – and describe – the options to address the problem; (iii) Policy-makers’ ability to identify 
and address barriers to implementing policy options; and (iv) Policy-makers’ ability to organise and run policy dialogues.
Implications for public
There is the need to package research data into effective policy tools and materials that will help policy-makers to make and implement evidence-
informed policy regarding infectious diseases of poverty (IDP) to improve public health. Policy brief is an effective evidence-packaging mechanism 
which can support evidence-informed policy-making (EIP) on IDP, hopefully improving the chances of successful policy implementation. Research 
has shown that policy briefs can make it easier for policy-makers and other stakeholders to determine how available evidence from research can be 
contextualized locally and accords with their own beliefs, values, interests, or political goals and strategies.
Key Messages 
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Background
In recent years, increasing attention has been paid to the 
use of research in the formulation of health policy as a way 
of enhancing its effectiveness.1 The process of utilizing 
evidence from research to make health policy is known as 
evidence-informed policy-making (EIP). EIP is characterized 
by the systematic and transparent access to, and appraisal 
of, evidence as an input into policy-making.2 Bowen and 
Zwi,3 noted that evidence encompasses research, and may 
include opinion and views of individuals or groups, results of 
consultative processes and published reports and documents. 
However, evidence from scientific research has been 
consistently shown to be among the most reliable category of 
evidence in the development of health policy.4-7 Oxman and 
colleagues2 in their report on SUPPORT tools for evidence-
informed health policy-making, cited several instances, such 
as the role of health services research in public policy-making; 
health policy-makers’ perceptions of their use of evidence; and 
healthcare management and policy-making which showed 
that in the reality, health policies are often not well-informed 
by research evidence.7-10 
Although there are promising experiences and a few 
documented success stories on how research evidence has 
been used to inform policy,11-13 the lack of effective use 
of research evidence in policy-making continues to be a 
major challenge in most low- and middle-income countries 
(LMICs) where health systems are weak and the burden of 
infectious diseases of poverty (IDP) is enormous. According 
to Oxman and colleagues,2 poorly-informed decision-making 
particularly in LMICs is one of the reasons why services 
sometimes fail to reach those most in need, why health 
indicators become off-track and why many affected countries 
are unlikely to be able to meet the health millennium 
development goals (MDGs). The World Health Organization 
(WHO) in the global report for research on IDP,14 noted that 
policy-makers need to have access to the right information at 
the right time to inform decisions that draw on the evidence 
of what works, and feed “best buys” into health policy, health 
budgets and the operations of health systems. The report 
further noted that research data must be rapidly translated 
into effective tools for policy-makers to enhance the control 
of IDP.14 
In Nigeria, the need to package research data into effective 
policy tools and materials that will help policy-makers to 
make evidence-informed policy regarding IDP cannot be 
overstated. Malaria, schistosomiasis and lymphatic filariasis 
(LF) are among the IDP with severe health burden in Nigeria 
which require effective policy tools for their control. According 
to the World Malaria Report of 2014, it was estimated that 
in 2013, 128 million people were infected with Plasmodium 
falciparum malaria in Sub-Saharan Africa at any one time.15 
In total, 18 countries accounted for 90% of infections in Sub-
Saharan Africa; 37 million infections (29%) arose in Nigeria 
and 14 million (11%) in the Democratic Republic of the Congo, 
the 2 countries with the highest numbers of infections.15 With 
regards to LF, available recent reports indicate that in Africa, 
34 countries are endemic, and Nigeria is believed to bear the 
highest burden of LF, with an estimated 80 to 120 million 
people at risk.16-18 In a recent review article, Adenowo and 
colleagues19 noted that schistosomiasis is the second most 
common neglected tropical disease after hookworm in Sub-
Saharan Africa and accounts for 93% (192 million) of the 
world estimated 207 million cases of schistosomiasis with 
the highest prevalence of the infection seen in Nigeria (29 
million).
Adam and colleagues20 observed that there is the growing 
recognition of the importance of developing concise materials 
and tools to communicate various types of information to 
policy-makers and those supporting them. They cited several 
reports where this recognition has led to the development of 
a plethora of information-packaging efforts, which aim to 
support action based on the messages arising from research 
and other policy-relevant information.21-23
There are numerous reports which have shown that the 
availability of timely, suitably packaged and policy relevant 
research evidence is important in supporting increased use 
of research evidence in the policy processes in LMICs.20-23 A 
number of studies have shown that effective techniques for 
communicating research findings to decision-makers include 
presenting readily understandable; timely data in visually 
compelling formats; using illustrative anecdotes where 
appropriate; sending clear key messages about the meaning of 
data; suggesting ways to use research findings for answering 
important policy questions; and establishing relationships of 
trust and credibility with policy-makers.24-27 
In a report on preparing and using evidence-informed 
policy briefs to support EIP, Lavis and colleagues,28 noted that 
policy brief is an effective evidence-packaging mechanism 
and a new approach to improving the policy-making process 
by supporting evidence-informed policy-making. They noted 
that policy briefs make it easier for policy-makers and other 
stakeholders to determine whether and how the available 
research evidence accords with their own beliefs, values, 
interests, or political goals and strategies.28 An effective policy 
brief has been described as one that makes the evidence 
concise and understand able; explains why the evidence is 
important; and describes evidence-informed policy options 
that would be suitable actions for policy-makers to take.29-31 
With a problem clarified in a policy brief, what is known 
and not known about the options clearly described, and key 
implementation considerations clearly flagged, policy-makers 
may be more readily able to identify viable ways forward.28
It is pertinent to state that despite the existence and 
importance of effective evidence-packaging mechanisms 
such as policy briefs in the promotion of EIP, most policy-
makers particularly in LMICs lack the capacity to develop and 
use them. In a WHO publication on enhancing capacity for 
evidence-informed health policy, it was observed that policy-
makers’ capacity to understand and use research (including 
evidence-packaging mechanisms) has been neglected, both 
as a research topic and as an area of investment in terms of 
promoting evidence-informed policy.32 
There are reports that have indicated a strong need for 
capacity-building, for policy-makers to enable them have a 
better understanding of scientific information packaged in 
various policy-relevant formats, along with civil servants in 
a number of ministries in national and local government.1,33,34 
Oxman and colleagues2 have argued that strengthening the 
use of research evidence (including through policy briefs), and 
the ability of policy-makers to make appropriate judgments 
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about its relevance and quality, is a critical challenge that 
holds the promise of helping to achieve significant health 
gains and better use of resources. 
A variety of techniques to accomplish capacity enhancement 
for policy-makers include sharing of information through 
publications, training workshops, mentoring, hosting 
and facilitating networks and knowledge services, and 
participating in and supporting relevant research.1,35 The 
objective of this study was to assess the usefulness of training 
workshops and mentoring to enhance the capacity and ethical 
standards of Nigerian health policy-makers from the State of 
Ebonyi to develop policy briefs on the control of IDP.
Methods
Study Design
A modified “before and after” intervention study design 
was used in this investigation as described by Purdon and 
colleagues.36 The outcomes were measured on the eligible 
population (target participants) both before the intervention 
is implemented and after. The difference between the before 
and after measurements was taken to be the impact of the 
intervention. In this instance, the ‘before’ – or ‘baseline’ 
– measurements served as the control measurements.36 
The study was divided into 2 stages: (i) Evidence to policy 
workshop; and (ii) Policy-makers’ mentorship meetings. 
Detailed description of these stages is provided in the relevant 
sections below.
 
Study Area and Participants
This study was conducted at subnational level and the 
participants were drawn from Ebonyi State in the South-
Eastern Nigeria. The target participants were the career health 
policy-makers, as described by Bammer and colleagues37 and 
these include health professionals in charge of the health 
system’s management; regional, state and local government 
directors of Ebonyi State health ministry; directors of primary 
healthcare at the local government level; health professionals 
working with specific programmes in the health ministry; 
staff and consultants involved in public health issues within 
the health ministry; programme/project managers under the 
health ministry; chief executive officers of civil society groups, 
including nongovernmental organizations (NGOs); and 
leaders of national health-based associations (for example, 
Nigeria Medical Association; National Association of Nigeria 
Nurses and Midwives; and Pharmaceutical Association of 
Nigeria).
Evidence-to-Policy Workshop
A total of 50 policy-makers were mapped out for this study. 
We organized a one-day evidence-to-policy workshop at 
the Ebonyi State Civil Service Staff Development Centre 
Abakaliki Nigeria, for the policy-makers. The focus of the 
evidence-to-policy workshop was to enhance the participants’ 
capacity to develop evidence-informed policy briefs on IDP 
in Ebonyi State. The topics and content of the evidence-to-
policy workshop are outlined in Table 1. All the policy-
makers were invited to the workshop by invitation letters 
which were sent 2 weeks before the event and was followed-
up with a text message reminder to their mobile phones a 
day before the programme. Of the 50 invited policy-makers 
43 individuals attended. The workshop was held in October 
2014. The duration of the workshop was 7 hours from 9 am to 
4 pm (with a break between 12 Noon to 1 pm). 
A preworkshop assessment questionnaire (developed in a 
4-point Likert scale according to the degree of adequacy; 1 = 
grossly inadequate, 4 = very adequate), was administered prior 
to actual training to assess the level of knowledge and capacity 
of the participants on the specific topics to be covered within 
the theme of the workshop. After the administration of the 
preworkshop questionnaire the training commenced and was 
facilitated by 4 resource persons (3 senior researchers from 
Ebonyi State University and 1 senior director from the health 
ministry). All teaching sessions lasted 35–45 minutes and 
were done using PowerPoint presentation and handouts on 
each topic were produced and distributed to all participants. 
Questions/answers/discussions lasting from 30–40 minutes 
followed each teaching session. It was made mandatory for 
all lectures to be delivered in simplified, practical and easily 
comprehensible patterns. All teachings and discussions 
irrespective of the topical area focused on IDP. Emphasis 
was placed on development of policy on the control of 
malaria, schistosomiasis and LF in Ebonyi State. At the end 
Table 1. Topics and Content of the Evidence-to-Policy Workshop for Policy-Makers  in Ebonyi State Nigeria
Topical Area Contents
Collaborative initiative and the 
benefits in health policy-making 
for control of IDP
The principles and framework of collaborative initiative; setting vision for collaboration; setting out the guiding 
principles for collaboration; defining and setting goals and objectives of collaborative initiative; roles and responsibilities 
of collaborative initiative; implementation requirements in collaborative initiative; and the evaluation process of 
collaborative initiative
Preparation and use of policy 
briefs in health policy-making 
for control of IDP
Agenda/priority setting; policy briefs in health policy-making; process of preparation of policy briefs; the key ingredients 
of effective policy briefs; structure/outline of a policy brief ; value of policy briefs in health policy development
Policy dialogue in health policy-
making for control of IDP
Policy dialogues in health policy-making; the importance of policy dialogue in the health systems and public health reform; 
policy dialogue as an interactive knowledge-sharing mechanism; procedure for organising and using policy dialogues to 
support EIP; characteristics and features of policy dialogues; the differences between dialogue and debate 
Ethics in health policy-making, 
research and implementation 
for control of IDP
Ethics in health policy research and implementation; the basic principles of ethics that must be implemented; balancing 
ethical concerns with economic realities; impact of various policies on the vulnerable population; the principles of justice, 
equity and autonomy; the ethical issues in health systems research
Health policy and politics in 
Ebonyi State
Principles of health policy and politics; how local politics can affect health policy formulation and implementation; how 
to manage political interference in the health policy-making process and implementation
Abbreviations: IDP, infectious diseases of poverty; EIP, evidence-informed policy-making.
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of the workshop, a postworkshop assessment questionnaire 
(also developed in a Likert scale format) was administered 
to the participants to evaluate the impact of the workshop. 
In preparation for the policy-makers’ mentorship meetings 
(described below), at the end of the evidence-to-policy 
workshop participants were classified into 3 mentorship 
groups (malaria policy brief group; schistosomiasis policy 
brief group; and LF policy brief group). The classification 
was done according to participants’ area of interest and work. 
Each policy group had 10–15 policy-makers as members and 
had 2 mentors assigned to each group. The mandate of each 
group was to develop a policy brief.
Policy-makers’ Mentorship Meetings
The mentorship meetings took place from November 
to December 2014. The purpose of the policy-makers’ 
mentorship meetings was to provide technical guidance 
to each of the policy-makers’ policy group to enable them 
produce the respective policy briefs. A “formal group 
mentorship” approach described by the Canadian Coalition 
for Global Health Research38 was adopted in this study. The 
knowledge acquired during the evidence-to-policy workshop 
was put into use in the mentorship meetings. A total of four 
senior researchers from Ebonyi State University and one 
senior director from the health ministry served as mentors 
and provided technical guidance to the policy-makers’ groups. 
The meetings were practical oriented and provided for full 
participation of every group member. Within the period of 
the mentorship, 2 major group meetings were held by each 
group (lasting 2–3 hours); these were in addition to the several 
individual meetings/contacts with the mentors by members 
of the respective groups. During the first major group 
meeting of each group, participants identified potential policy 
options/recommendations for the control of their respective 
IDP of focus. The policy options were based on their personal 
professional experiences, tacit knowledge, expert opinion and 
to some extent known research evidence. These policy options 
were subjected to “research evidence synthesis” (implies 
synthesising evidence largely from systematic reviews) by 
the each group to identify the options that have the support 
of research evidence. Research evidence (mostly systematic 
review) was sought from PubMed, Cochrane database and 
Google Scholar. During the second major group meeting, 
the policy options with sufficient research evidence were 
identified, deliberated upon and adopted for the policy brief 
drafting. Two members of each group were selected by the 
various groups to make a policy presentation of each group’s 
resolution at a scheduled multi-stakeholders policy dialogue. 
Data Analysis
The data collected via the questionnaire was analyzed using 
the methods developed at McMaster University Canada by 
Johnson and Lavis.39 The analysis is based on mean rating 
(MNR), median rating (MDR) and range. For instance the 
figures represent Likert rating scale of 1–4 points, where 
1 point = grossly inadequate; 2 points = inadequate; 3 
points = fairly adequate; and 4 points = very adequate. The 
main parameter measured was participants’ perceptions of 
their own knowledge/understanding. In terms of analysis, 
values ranging from 1.00–2.49 points are considered low, 
Table 2. Profiles of the Participants During the Evidence-Based Policy-
Making Capacity Enhancement Workshop in Ebonyi State Nigeria
Participant (Respondents) Attributes No. (%) of Participants (Respondents), N = 38
Gender  
Female 22 (57.89)
Male 16 (42.11)
Age (y)  
25–34 5 (13.16)
35–44 11 (28.95)
≥45 22 (57.89)
Institutional affiliation  
Federal Teaching hospital 12 (31.58)
State Ministry of Health 7 (18.42)
Local Government Service Commission 14 (36.84)
NGO 3 (7.89)
Educational institution 1 (2.63)
(Missing) 1 (2.63)
Official designation  
Programme officer/project secretaries 12 (31.58)
Managers/heads of departments 16 (42.11)
Directors/presidents/chairpersons 10 (26.32)
Years of experience in current designation  
<3 11 (28.95)
3–5 10 (26.32)
6–10 14 (36.84)
>10 3 (7.89)
Influence on policy-making  
Direct (DIPP) 21 (55.26)
Indirect (IIPP) 15 (39.47)
(Missing) 2 (5.26)
Highest academic qualification  
SSCE/diploma 2 (5.26)
Bachelor 25 (65.79)
Masters 8 (21.05)
Doctorate 2 (5.26)
(Missing) 1 (2.63)
DIPP, direct influence on policy-making process; IIPP, indirect influence 
on policy-making process; SSCE, senior school certificate; NGO, 
nongovernmental organizations.
whereas values ranging from 2.50–4.00 points considered 
high. The preworkshop means were compared to the 
postworkshop means. The EPi Info software was used for the 
performance of the data analysis.
Result
A total of 43 policy-makers out of the 50 individuals invited 
attended the workshop. The profile of the participants is 
presented in Table 2 and included the following: programme 
officer/project secretaries (31.58%); managers/heads of 
departments (42.11%); directors/presidents/chairpersons 
(26.32%). A total of 55.26% of the participants have direct 
influence on the policy-making process, with 65.79% 
and 21.05% possessing bachelors and masters degrees as 
highest academic qualifications, respectively. The outcome 
of the assessment of the impact of the workshop with the 
comparison of the preworkshop means and postworkshop 
means is presented in Table 3. Result also showed progressive 
increase in the postworkshop mean over the preworkshop 
mean. 
In terms of the “collaborative initiative,” the preworkshop mean 
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Table 3.  Comparison of the Preworkshop and Postworkshop Knowledge/Skill Assessment of Participants at the  Evidence-to-Policy Training Workshop for 
the Research Capacity Strengthening and Knowledge Management for Policy-Makers in Ebonyi State Nigeria
Parameter Assessed
Preworkshop 
Mean
Postworkshop 
Mean
Mean 
Increase (%)
Collaborative Initiative
(i) How would you rate your understanding of the principles and framework of collaborative initiative in health 
policy-making? 
3.03 3.68 0.65 (21.45)
(ii) How would you describe your knowledge of setting vision for collaboration and the benefits in health policy-
making? 
2.97 3.63 0.66 (22.22)
(iii) How would you describe your knowledge of setting out the guiding principles for collaboration and the 
benefits in health policy-making? 
2.89 3.63 0.74 (25.61)
(iv) How would you rate your understanding of defining and setting goals and objectives of collaborative 
initiative in health policy-making? 
2.92 3.74 0.82 (28.08)
(v) How would you describe your ability to understand and define roles and responsibilities of collaborative 
initiative in health policy-making? 
3.00 3.63 0.63 (21.00)
(vi) How would you rate your understanding of implementation requirements in collaborative initiative in health 
policy-making? 
2.69 3.47 0.78 (29.00)
(vii) How would you rate your understanding of the evaluation process of collaborative initiative in health policy-
making? 
2.68 3.61 0.93 (34.70)
Policy Briefs
(i) How would you describe your level of knowledge of agenda/priority setting in the development of health 
policy? 
2.89 3.73 0.84 (29.07)
(ii) How would you rate your understanding of policy briefs in health policy-making?   2.79 3.61 0.82 (29.39)
(iii) How would you describe your level of knowledge of the process of preparation of policy briefs in the 
development of health policy? 
2.58 3.63 1.05 (40.70)
(iv) How would you describe your level of knowledge of the key ingredients of effective policy briefs in the 
development of health policy? 
2.49 3.61 1.12 (45.98)
(v) How would you describe your level of knowledge of the structure/outline of a policy brief in the development 
of health policy? 
2.54 3.47 0.93 (36.61)
(vi) How would you describe your level of knowledge of the value of policy briefs in the development of health 
policy? 
2.82 3.66 0.84 (29.79)
Policy Dialogue
(i) How would you rate your understanding of policy dialogues in health policy-making?   2.79 3.63 0.84 (30.11)
(ii) How would you rate your knowledge of the importance of policy dialogue in the health systems and public 
in health reform? 
3.00 3.61 0.61 (20.33)
(iii) How would you describe your understanding of the developments that necessitate hosting a policy dialogue 
as an interactive knowledge-sharing mechanism?
2.68 3.50 0.82 (30.60)
(iv) How would you rate your knowledge of the procedure for organising and using policy dialogues to support 
EIP? 
2.76 3.50 0.74 (26.81)
(v) How would you rate your understanding of the characteristics and features of policy dialogues in health 
policy-making? 
2.70 3.42 0.72 (26.67)
(vi) How would you describe your understanding of the differences between dialogue and debate with respect 
to the health policy-making process?
2.89 3.59 0.70 (24.22)
Ethics in Health Policy Research and Implementation
(i) How would you rate your understanding of ethics in health policy research and implementation?   2.76 3.74 0.98 (35.51)
(ii) How would you rate your knowledge of the basic principles of ethics that must be implemented in virtually 
any context in health policy-making? 
2.71 3.76 1.05 (38.75)
(iii) How would you describe your understanding of balancing Ethical concerns with economic realities with 
respect to the health policy-making process?
2.53 3.66 1.13 (44.66)
(iv) How would you describe your understanding of impact of various policies on the vulnerable population with 
respect to the health policy-making process?
2.61 3.70 1.09 (41.76)
(v) How would you rate your knowledge of the principles of Justice, equity and autonomy in health policy-making 
process? 
2.76 3.73 0.97 (35.14)
 (vi) How would you rate your knowledge of the ethical issues in health service research? 2.79 3.78 0.99 (35.48)
Health Policy and Politics in Ebonyi State
(i) How would you rate your understanding of the principles of health policy and politics in Ebonyi State?   2.89 3.47 0.58 (20.07)
(ii) How would you rate your knowledge of how local politics can affect health policy formulation and 
implementation? 
3.03 3.59 0.56 (18.48)
(iii) How would you describe your understanding of how to manage political interference in the health policy-
making process and implementation?
2.87 3.62 0.75 (26.13)
Abbreviations: IDP, infectious diseases of poverty; EIP, evidence-informed policy-making.
Uneke et al
International Journal of Health Policy and Management, 2015, 4(9), 599–610604
ranged from 2.69–3.03, while the postworkshop mean ranged 
from 3.47–3.74, with the percentage increase ranging from 
21.00%–34.70%. In terms of “preparation and use of policy 
briefs,” the preworkshop mean ranged from 2.49–2.89, while 
the postworkshop mean ranged from 3.47–3.73, with the 
percentage increase ranging from 29.07%-44.98%. In terms of 
“policy dialogue,” the preworkshop mean ranged from 2.68-
3.00, while the postworkshop mean ranged from 3.42–3.63, 
with the percentage increase ranging from 20.33%-30.60%. 
Concerning “ethics in health policy-making” the preworkshop 
mean ranged from 2.53–2.79, while the postworkshop mean 
ranged from 3.66–3.78, with the percentage increase ranging 
from 35.14%-44.66%. With regard to “health policy and 
politics,” the preworkshop mean ranged from 2.87–3.03, while 
the postworkshop mean ranged from 3.47–3.62, with the 
percentage increase ranging from 18.48%-26.13% (Table 4). 
The outcome of the group mentorship meetings is presented 
in Tables 5, 6 and 7. Of the 13 policy options recommended 
by the malaria policy brief group, 5 options were eventually 
accepted after the “evidence synthesis” (ie, synthesising 
evidence largely from systematic reviews).40-47 These included 
the following: (i) Distribution of insecticide treated bed-
nets (ITNs) to be more effective, proper orientation on the 
usage; (ii) Laboratory diagnosis of malaria to be considered 
along clinical assessment before treatment of malaria; (iii) 
artemisinin combination therapies (ACTs) recommended 
but quality control must be ensured; (iv) More funding for 
research on indigenous malaria drugs; and (v) Vector control 
using indoor residual spraying and larval source management. 
The option on restriction of antimalarial prescription as an 
over the counter (OTC) drug, was replaced with option that 
chemists to perform rapid diagnostic test for malaria (RDT) 
before giving antimalarials (Table 5). Of the 10 policy options 
recommended by the schistosomiasis policy brief group, 
only 3 were accepted after the evidence synthesis.48-50 These 
included the following: (i) Control of snail vectors; (ii) Periodic 
enlightenment of the community/health education/part of 
school training curriculum on communicable diseases; and 
(iii) Mass screening/chemotherapy. The rest were rejected due 
to lack of sufficient research evidence supporting their use 
for policy (Table 6). Of the 11 policy options recommended 
by the LF policy brief group, only 5 were accepted after the 
evidence synthesis.51-56 These included the following: (i) 
Establishment of a standard protocol for diagnosis for LF; 
(ii) Vector control; (iii) Community directed distribution of 
long lasting insecticide treated bed-net  (LLN) and Mectizan 
(Mass chemotherapy)/health education; (iv) Integrated 
control policy (onchocerciasis, schistosomiasis, and LF); 
and (v) Establishment of policy monitoring/evaluation 
(feedback mechanism)/with training and capacity building. 
The remaining options were rejected because of absence of 
sufficient evidence (Table 7).
Discussion
The outcome of this study suggests that policy-makers’ 
knowledge and capacity to develop evidence-informed 
Table 4. Participants Written Comments at the End of the Evidence-to-Policy Workshop for Policy-Makers in Ebonyi State
1. The workshop is an eye opener to the context of influencing policy direction at our levels ensuring best practices and encouraging team/collaborative 
approach.
2. The workshop is been very interesting but there is no time to digest the papers well. We need more of this programme.
3. The lectures were well-packaged and educating. 
4. I appreciate the organiser for their elaboration and in-depth knowledge about EIP. 
5. My observation is that this course should be extended to more days not only one day.
6. This training is very good for policy influencers like us.
7. Political stakeholders should be involved in this project because this will enable them realize their role and collaborate with us. 
8. This training is very educating and brain storming  and must be continued.
9. I am better informed now about the global best practices of health policy-making. 
10. The papers presented were all master piece in my every day activities.
11. Interesting and eye opener in policy-making decision process.
12. Workshop of this kind should be organised regularly for us to be masters in the process. 
13. Bureaucracy and administrative bottleneck often impede us from acting and going what we are supposed to do what will you do about these things?
14. This health policy programme should be organised least every 3 months for us to be well-equipped in the rudiments policy-making.
15. This programme should be sustained by organising it every month.
16. This is very beneficial to policy-makers and influencers.
17. More political advocacy in order to help us break through with its implementations.
18. Some knowledge are not very adequate. 
19. This has increased my knowledge on policy brief especially its collaborative nature. 
20. This is very vital for us the policy-makers  and periodic interaction like this should be encouraged and sustained.
21. This workshop is what we need to be part of. 
22. The presentations are very friendly and understandable we pray for the presenters for more wisdom.
23. There must be more practical approach this than academics because the rivals between politics and needs will not give us a favourable ground to 
implement this evidenced-based policy-making process.
Abbreviation: EIP, evidence-informed policy-making.
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policy materials such as policy briefs can be enhanced via 
a one day training workshop followed by a mentorship 
program. The Ebonyi State University provided the enabling 
platform for the study team to execute this training and 
mentorship venture designed to promote evidence-to-policy 
link. According to WHO, the education sector, especially 
universities, has a role to play in building capacity and 
fostering interdisciplinary learning in a new generation 
of scientists and policy-makers.14 We adopted training 
workshop in this evidence-to-policy capacity enhancement 
initiative because of its many strategic benefits. The report of 
healthcare information for all (HIFA)57 highlighted some of 
the benefits of training workshop (when used as in-service 
training) to include presenting new information to groups of 
people, practicing new skills and allowing health workers to 
share experiences and insights. The methods we adopted in 
the workshops include the use of preworkshop questionnaire 
and postworkshop questionnaire; general discussions; group 
works and short presentations have been shown to be very 
effective in capacity enhancement of decision makers.58 The 
comments from selected participants concerning the outcome 
of the workshop, clearly showed that notable improvement in 
knowledge and capacity was achieved (Table 3). One policy-
maker stated thus: “I am better informed now about the global 
best practices of health policy-making”; another noted that: 
“The workshop is an eye opener to the context of influencing 
policy direction at our levels ensuring best practices and 
encouraging team and collaborative approach.” 
Unlike training workshops, mentoring is rarely applied in 
the enhancement of policy-makers’ capacity for knowledge 
management as well as evidence-based policy-making. In 
a previous report, Bennett et al59 noted that mentoring has 
emerged as a critical strategy and key to enhance capacity for 
evidence-based policy-making and health systems research. 
In this study the success in the process of guiding the policy-
makers to be able to identify policy options and subject the 
options to evidence synthesis suggest that mentorship can 
be a vital tool in policy-makers’ capacity enhancement. The 
Canadian Coalition for Global Health Research (CCGHR) 
report38 described mentorship as a resource for building 
sustainable capacity, fostering research capacity and 
nurturing leadership development in the context of limited 
resources. Furthermore the report noted that a very vital 
aspect of mentorship is that it plays a critical role in this 
Table 5. Malaria Control Policy Recommendations and Outcome of Evidence Synthesis by the Malaria Policy Brief Group
Policy Options Recommended Before 
Evidence Synthesis
Outcome of Evidence Synthesis of Policy Options Recommended
Group Conclusion and Final 
Recommendation
(1) Environmental manipulation, 
modification, and management (provision 
of good drainage system)
No available evidence as a feasible strategy for malaria control policy. 
Alternative: Larval source management under vector control feasible.
Key Reference: Tusting et al40 
Policy option rejected. 
Alternative accepted as policy 
recommendation.
(2) Proper refuse disposal No available evidence as a feasible strategy for malaria control policy. Policy option rejected.
(3) Sanctions for environmental sanitation 
violators
No available evidence as a feasible strategy for malaria control policy. Policy option rejected.
(4) Private sector involvement in 
management of waste disposal
No available evidence as a feasible strategy for malaria control policy. Policy option rejected.
(5) Distribution of ITNs to be more 
effective, proper orientation on the usage
There is sufficient evidence to show it is an effective strategy for malaria 
control policy. Key reference: Gamble et al41 
Policy option accepted.
(6) Use of drugs to eradicate the parasite 
in the population (mass chemotherapy 
with gametocidal agent)
There is evidence to show that it is an effective strategy for malaria control. 
However there are serious implementation challenges especially with the 
sustainability of this strategy. Its feasibility as a policy recommendation for 
Ebonyi is doubtful. Key reference: Poirot et al42 
Policy option rejected.
(7) Provision of portable water No available evidence as a feasible strategy for malaria control policy. Policy option rejected.
(8) Laboratory diagnosis of malaria to 
be considered along clinical assessment 
before treatment of malaria should be 
considered
There is sufficient evidence to show it is an effective strategy for malaria 
control policy. Key reference: Odaga et al43 
Policy option accepted.
(9) Restriction of antimalarial prescription 
as an OTC drug to prevent resistance 
(strengthen PHCC in rural areas)
There is insufficient evidence to show that it can be an effective strategy 
for malaria control. There can be serious implementation challenges 
especially with the sustainability of this strategy. Its feasibility as a policy 
recommendation for Ebonyi is doubtful, except if the PHCC is greatly 
strengthened. Alternative: Chemists to perform RDT before giving 
antimalarials. Key reference: Abuya et al44 
Policy option rejected. 
Alternative accepted as policy 
recommendation.
(10) ACTS recommended but quality 
control must be ensured
There is sufficient evidence to show it is an effective strategy for malaria 
control policy. Key reference: Ogbonna and Uneke45 
Policy option accepted.
(11) Improvement of incentives to the 
rural health workers
No available evidence as a feasible strategy for malaria control. Beyond the 
scope of malaria policy alone. This is a health sector general problem. 
Policy option rejected.
(12) More funding for research on 
indigenous malaria drugs
There is sufficient evidence to show it is an effective strategy for malaria 
control policy. Key reference: Amoa Onguéné et al46 
Policy option accepted.
(13) Vector control using indoor residual 
spraying and larval source management
There is sufficient evidence to show it is an effective strategy for malaria 
control policy. Key references: Tusting et al40; Pluess et al47
Policy option accepted.
Abbreviations: OTC, over the counter; ITN, insecticide treated bed-net; PHCC, primary health care centre; RDT, rapid diagnostic test for malaria; ACT, 
artemisinin combination therapy.
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cycle of sustainable capacity building by developing the skills, 
knowledge, experiences and capacities through creating 
environments of continuous learning and sharing.38
The result of this study showed a notable improvement in 
the knowledge and capacity of the participants regarding the 
process of developing evidence-informed policy brief. This 
notable improvement is demonstrated by the tremendous 
increase in the postworkshop mean of knowledge/skill over 
that of the preworkshop mean in all the subject areas covered 
at the evidence-to-policy workshop. It is worth noting 
that among the areas of greatest knowledge and capacity 
improvement was in the development of evidence-informed 
policy brief. The percentage increase in knowledge ranged 
from 36.61% to 45.00% for knowledge of the process of 
preparation of policy briefs; knowledge of the key ingredients 
of effective policy briefs; and knowledge of the structure/
outline of a policy brief. This perhaps suggests that it may be 
the area of the policy-makers’ greatest capacity constraint in 
EIP process. Deans and Ademokun1 had argued that those 
who seek to build capacity for evidence-informed policy 
need to understand the actual capacity gaps of policy-makers. 
Nonetheless, preparing and using policy briefs by policy-
makers requires a range of knowledge and skills, including the 
ability to clarify problems, to decide on – and describe – the 
options to address the problem, to identify and address 
barriers to implementing the options, and to organise and 
run policy dialogues.35 Securing this capacity among policy-
makers will help to ensure that policy briefs are produced and 
used more effectively and efficiently.35
Apart from enhancing policy-makers’ ability to develop 
policy briefs, we incorporated other vital policy relevant 
subjects including collaborative initiative; health policy 
and politics; and ethics in policy-making/implementation. 
According to Green and Bennett,32 policy-making does 
not take place in a vacuum: political, economic and social 
factors all affect how policies are made, and who makes 
them, at all levels. We introduced collaborative initiative to 
demonstrate to the policy-makers that policy-making is a 
multidisciplinary venture requiring the partnership with all 
relevant stakeholders. This is because partnerships provide 
a means of bridging complementary disciplines and provide 
opportunities for capacity strengthening through ideas and 
skills.32 The importance of politics in the health policy-making 
process cannot be ignored. Green and Bennett32 noted that 
policy process is political and often involves contestation 
between actors whose beliefs, values, knowledge and interests 
do not necessarily coincide. This explains why Prewitt60 
argued for a change in metaphor from evidence-based policy 
to evidence-influenced politics, which acknowledges the 
central role played by political factors. According to Overseas 
Development Institute (ODI),61 the policy process and the 
production of research are in themselves political processes 
from start to finish. 
This is why we integrated the political process in this study 
as a vital capacity enhancement area for the policy-makers. 
Our take on this is that if the policy-makers have a better 
understanding about the relationship between policy-making 
and politics they will be able to make effective policy. We 
also gave consideration to the subject of ethics in policy-
making and enhanced the knowledge of the participants on 
how to apply it in policy-making. According to Aarons,62 
the development of policies in health and healthcare 
should incorporate ethical premises as well as thoughtful 
consideration of the values pertinent to the particular society 
Table 6. Schistosomiasis Control Policy Recommendations and Outcome of Evidence Synthesis by the Schistosomiasis Policy Brief Group 
Policy Options Recommended 
Before Evidence Synthesis
Outcome of Evidence Synthesis of Policy Options Recommended Group Conclusion and 
Final Recommendation
(1) Provision of restriction around 
ponds/streams/rivers
There is no clear evidence to show that it is an effective strategy for schistosomiasis 
control policy. It is likely to constitute serious implementation challenges especially with 
the sustainability.
Policy option rejected
(2) Control of snail vectors There is sufficient evidence to show it is an effective strategy for schistosomiasis control 
policy. Key reference: Yuan et al48
Policy option accepted
(3) Periodic enlightenment of the 
community/health education/part 
of school training curriculum on 
communicable diseases
There is sufficient evidence to show it is an effective strategy for schistosomiasis control 
policy. Key reference: Hu et al49
Policy option accepted
(4) Ensuring that every home has 
functional toilet 
No available evidence as a stand-alone strategy for schistosomiasis control policy. Beyond 
the scope of schistosomiasis policy alone. This is a health sector general problem.
Policy option rejected
(5) Adequate provision of 
accessible portable water  
No available evidence as a stand-alone strategy for schistosomiasis control policy. Beyond 
the scope of schistosomiasis policy alone. This is a health sector general problem.
Policy option rejected
(6) Immediate treatment of 
identified cases of infection
There is evidence indicating that this should be integrated into the mass screening/
chemotherapy  control  policy  recommendation. 
Policy option rejected
(7) Mass screening/chemotherapy There is sufficient evidence to show it is an effective strategy for schistosomiasis control 
policy. Key reference: Su et al50
Policy option accepted
(8) Improved sanitation No available evidence as a stand-alone strategy for Schistosomiasis control policy. Beyond 
the scope of schistosomiasis policy alone. This is a health sector general problem.
Policy option rejected
(9) Provision of affordable and 
accessible lab services/screening 
centres in the rural areas
No available evidence as a stand-alone strategy for schistosomiasis control policy. Beyond 
the scope of schistosomiasis policy alone. This is a health sector general problem.
Policy option rejected
(10) Disease  notification and 
surveillance in the rural areas
No available evidence as a stand-alone strategy for schistosomiasis control policy. Beyond 
the scope of schistosomiasis policy alone. This is a health sector general problem.
Policy option rejected
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and the goals to be achieved by specific policies. He further 
noted that social inequalities, changing values, and emergent 
challenges to traditional beliefs, add complexities that require 
a thorough analysis to compile policies that are fair and 
equitable.62
It was of interest to note that the participants were able to 
perform evidence synthesis for the policy briefs to identify and 
select policy options that were supported by relevant research 
evidence (Tables 5, 6 and 7). Five policy options were selected 
out of 13 for malaria, 3 out of 10 for schistosomiasis and 5 out 
of 11 for LF. The policy-makers through this process gained 
understanding on how to subject a policy recommendation 
to evidence synthesis to assess its relevance to policy. They 
also appreciated the enormous value of research evidence 
and the importance of demanding for it in policy-making. 
Through this approach we promoted the “pull effort” among 
the policy-makers. According to the WHO,63 pull efforts are 
utilized in situations where knowledge users value the use of 
research and recognize the need to address an information 
gap. Sheldon64 added that as the knowledge base is being put 
together in a more coordinated, explicit and credible way, so 
the demands for policy-makers and practitioners to use this 
information in their decision-making grows. 
It is important to note that workshop and the mentoring in 
this study simultaneously improved the exchange and linkage 
of the participants and the researchers/mentors. Lavis and 
colleagues,23 noted in their report that such exchange and 
linkage enhance evidence-to-policy link and knowledge 
translation (referred to as the integrated model). It is 
interesting to note that the policy-makers continue to receive 
support from the mentors (researchers) even after the end of 
the training workshop main activities. It is well-established 
that a major factor that can bridge the gaps in evidence to 
policy process is sufficient contact between researchers 
and policy-makers.65 In our previous study, participants in 
the focus group discussion conducted in this study were in 
consensus that collaboration between researchers and policy-
makers was needful so as to align researchers more specifically 
to operational problems inherent in the health systems from 
the policy-making perspective.66
A very notable initiative in this study was the inclusion in the 
content of the training of policy-makers of topics on ethics in 
policy-making, and policy implementation which seldom are 
addressed in EIP initiatives.67 Hyder and colleagues68 noted 
in their report that ethics is gradually being integrated into 
public-health policy decisions in many developing health 
systems, even though it is often implicit and undervalued. 
They added that while there have been extensive explorations 
Table 7. LF Control Policy Recommendations and Outcome of Evidence Synthesis by the LF Policy Brief Group
Policy Options Recommended Before 
Evidence Synthesis
Outcome of Evidence Synthesis of Policy Options Recommended
Group Conclusion and 
Final Recommendation
(1) Establishment of a standard protocol 
for diagnosis of LF
There is sufficient evidence to show it is an effective strategy for LF control policy. 
Key reference: Weil et al51
Policy option accepted
(2) Establishment of game reserve No available evidence as a feasible strategy for LF control. Policy option rejected
(3) Vector control There is sufficient evidence to show it is an effective strategy for LF control policy. 
Key reference: Bockarie et al52 
Policy option accepted
(4) Public health education on LF No available evidence as a stand-alone strategy for LF control. Alternative: Integrated 
into the community directed mass chemotherapy. Key reference: Nandha and 
Krishnamoorthy53 
Policy option rejected. 
Alternative accepted as 
policy recommendation
(5) Consider LLN distribution doc/policy 
to highlight LF
There is evidence indicating that this should be integrated into the community 
directed mass chemotherapy. Not as a stand-alone policy. 
Policy option rejected
(6) Community directed distribution 
of LLN and Mectizan (Mass 
chemotherapy)/health education 
There is sufficient evidence to show it is an effective strategy for LF control policy. 
Key reference: Blackburn et al54
Policy option accepted
(7) Policy harmonization/adapting 
national policies on PHC
No available evidence as a stand-alone strategy for LF control policy. Beyond the 
scope of LF policy alone. This is a health sector general problem.
Policy option rejected
(8) Integrated control policy (STH, 
Oncho, Schisto, LF) 
There is sufficient evidence to show it is an effective strategy for LF control policy. 
Key reference: Hopkins et al55 
Policy option accepted
(9) Establishment of policy monitoring/
evaluation (feedback mechanism)/with 
training and capacity building
There is sufficient evidence to show it is an effective strategy for LF control policy. 
Key reference: Molyneux56
Policy option accepted
(10) Sustainability issues should be 
taken into consideration
No available evidence as a stand-alone strategy for LF control policy. Beyond the 
scope of LF policy alone. This is a health sector general problem. Rather, Integrate 
sustainability into the policy implementation strategies. 
Policy option rejected 
(11) Success stories of previous policies 
and lessons learnt be adopted in LF 
policy formulation
No available evidence as a stand-alone strategy for LF control policy. Beyond the 
scope of LF policy alone. This is a health sector general problem.
Policy option rejected 
Abbreviations: LF, lymphatic filariasis; LLN, long lasting insecticide treated bed-net; PHC, primary health care; STH, soil transmitted helminth infection; 
Oncho, onchocerciasis; Schisto, schistosomiasis.
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of public-health policy in LMICs (such as by WHO), they have 
tended to focus on the attributes of specific health policies and 
systems rather than the role of ethics in the policy process.68 
Ethical issues highlighted in this study such as balancing 
ethical concerns with economic realities; impact of various 
policies on the vulnerable population; and the principles of 
justice, equity and autonomy in policy-making are vital factors 
that are often not given due consideration in low-income 
settings. Because studies on ethics in health policy-making 
and implementation are scarce more studies are not only 
needed in this field but also policy-makers should be trained 
to identify local values and public-health policies through 
valid research, and the provision of complementary support 
and guidance to promote social justice, accountability and 
preventive practices in an inherently unstable environment.68 
Conclusion
It is pertinent to state that the result of this study clearly 
suggests that an evidence-to-policy capacity enhancement 
workshop combined with a mentorship programme can 
improve policy-makers’ capacity for EIP. There are two major 
limitations to this study. First, the short period of time for 
the capacity enhancement workshop (2 days) and that of 
the mentorship programme (2 months) may not have been 
very sufficient to build real capacity in the policy-makers 
to produce evidence tools such as policy briefs. One of the 
participants commented thus: “The workshop has been very 
interesting but there is no time to digest the papers well. We 
need more of this programme.” Another policy-maker added 
that: “This health policy programme should be organised 
at least every three months for us to be well-equipped in the 
rudiments of policy-making.” According SURE Collaboration 
report,35 preparing and using policy briefs requires a range 
of knowledge and skills, and typically these competencies 
need to be developed over a period of years. The second 
limitation has to do with the self-assessment technique 
used to evaluate study outcome. Deans and Ademokun,1 
highlighting the weakness of this technique noted that being 
able to critically recognize and understand one’s own gap in 
skills and knowledge is a difficult process which takes guided 
thought. Despite these limitations, there is little doubt that 
workshops and mentorship programmes can be used for 
policy-makers’ capacity enhancement. We recommend that 
future studies could increase the duration of this type of 
capacity enhancement initiative and a more robust evaluation 
mechanism can be employed such as the diagnostic technique 
proposed by Haahr and colleagues.69 Furthermore we propose 
that additional work is necessary to assess the impact of 
the capacity of policy-makers to implement their crafted 
policies and assess the impact of the workshop to consolidate 
a sustainable knowledge translation platform that combines 
policy-makers and researchers/mentors by establishing 
constant exchanges and linkages among them.
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